Your email has been successfully added to our mailing list.

×
0 -0.00757575757575758 -0.0151515151515152 -0.0303030303030303 -0.0530303030303031 -0.0454545454545455 -0.0606060606060607 -0.106060606060606
Stock impact report

Cellect up 27% on positive results from Cell2in collaboration [Seeking Alpha]

Cellect Biotechnology Ltd. - American Depositary Shares (APOP) 
US:NASDAQ Investor Relations: cellect.co
Company Research Source: Seeking Alpha
Cellect up 27% on positive results from Cell2in collaboration Cellect Biotechnology (NASDAQ: APOP reports Results of this third-party study further validate that Cellect's Apograft technology significantly improves both proliferation and functional capabilities of hematopoietic (HSC) and mesenchymal (MSC) stem cells originating from bone marrow, peripheral blood, umbilical cord, and adipose tissue. Shares are up 27% Show less Read more
Impact Snapshot
Event Time:
APOP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for APOP alerts
Opt-in for
APOP alerts

from News Quantified
Opt-in for
APOP alerts

from News Quantified